PRAEDICAT, INC. – Trademark Portfolio
Entity Type: 03
PRAEDICAT, INC. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 8 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 3 Nice Classification classes. Currently, 10 trademarks are registered and 1 is pending. Notable registered marks include COMETA, CHEMMETA, LITAGION, QUINDREX, and PRAEDICAT. The owner is based in Culver City, CA.
3525 Eastham Drive, Suite B
Culver City, CA 90232
Showing of trademarks Trademarks
Trademark Classifications
PRAEDICAT, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does PRAEDICAT, INC. have?
PRAEDICAT, INC. has 13 U.S. trademarks filed with the USPTO. Of these, 10 registered, 1 pending, 2 cancelled.
What trademark classes does PRAEDICAT, INC. file in?
PRAEDICAT, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 16 (Paper Goods). Class 42 covers scientific and technological services; industrial analysis and research services.
What are PRAEDICAT, INC.'s most well-known trademarks?
PRAEDICAT, INC.'s registered trademark portfolio includes well-known marks such as COMETA, CHEMMETA, LITAGION, QUINDREX, and PRAEDICAT. These are among 10 currently registered trademarks in the portfolio.
What is PRAEDICAT, INC.'s trademark registration success rate?
PRAEDICAT, INC. has a 83% trademark registration rate, with 10 out of 12 resolved applications resulting in successful registration. Currently, 1 application is pending review.